Want to see IN:PFIZER full AI Analyst Report?
PFIZER LIMITED (PFIZER) Stock Price & Analysis
PFIZER Stock Chart & Stats
- Day’s Range
- INR 3,672.30 - INR 3,775.40
- 52-Week Range
- INR 3,590.00 - INR 5,329.05
- Previous Close
- INR 3,760.40
- Volume
- 14.93K
- Average Volume (3M)
- 8,647
- Market Cap
- INR 168.67B
- Enterprise Value
- INR 185.51B
- Total Cash (Recent Filing)
- INR 30.88B
- Total Debt (Recent Filing)
- INR 0
- Price to Earnings (P/E)
- 22.9
- Beta
- 0.69
- Next Earnings
- Nov 03, 2026 (Est.)
- EPS Estimate
- 53.23
- Last Dividend Ex-Date
- Jul 17, 2026
- Dividend Yield
- 2.03%
Bulls Say, Bears Say
Bulls Say
Very Low Leverage
A very low and improving debt-to-equity profile limits balance-sheet strain and preserves financial flexibility. That resilience can support continued research and development, operating needs, and capital returns while reducing the company’s exposure to financing pressure over the next several quarters.
Strong Profitability
Consistently high profitability indicates that Pfizer Limited converts revenue into substantial earnings across its pharmaceutical operations. Durable margins provide internal funding for commercial activities and innovation, while also offering a stronger buffer against changes in product mix or market conditions.
Improved Cash Generation
The recent improvement in operating cash flow and close alignment between free cash flow and earnings point to stronger earnings quality. If sustained, this conversion can support reinvestment, distributions, and financial flexibility without relying as heavily on external funding.
Bears Say
Uneven Revenue Trend
The uneven revenue pattern indicates that top-line momentum has not been consistently durable across recent years. Although the latest rebound is encouraging, prior declines make future growth more dependent on sustaining product demand and maintaining commercial execution across operating markets.
Gross-Margin Pressure
A notable gross-margin decline can reduce the earnings contribution from each unit of revenue and may weaken the sustainability of profitability if it persists. The company remained profitable, but this change warrants monitoring because margin recovery is important for preserving operating leverage.
Cash-Flow Volatility
Earlier periods of weaker cash conversion show that reported earnings have not translated consistently into operating cash flow. Even with the recent improvement, this variability can complicate funding and capital-allocation planning if cash generation again diverges from accounting profits.
PFIZER LIMITED News
PFIZER FAQ
What was PFIZER LIMITED’s price range in the past 12 months?
What is PFIZER LIMITED’s market cap?
When is PFIZER LIMITED’s upcoming earnings report date?
How were PFIZER LIMITED’s earnings last quarter?
Is PFIZER LIMITED overvalued?
Does PFIZER LIMITED pay dividends?
What is PFIZER LIMITED’s EPS estimate?
How many shares outstanding does PFIZER LIMITED have?
What happened to PFIZER LIMITED’s price movement after its last earnings report?
Which hedge fund is a major shareholder of PFIZER LIMITED?
What is the TipRanks Smart Score and how is it calculated?
Company Description
PFIZER LIMITED
Pfizer Limited operates as a pharmaceutical company, engaged in the development, promotion, sale, and international export of medicinal products. Its diverse product range addresses numerous therapeutic needs, such as those related to the neuro/central nervous system, hormonal balance, cardiovascular health, hemophilia, infectious diseases, gynecology, pain relief, orthopedic conditions, oncology, urology, parasitic infections, gastrointestinal disorders, vaccinations, respiratory ailments, and nutritional supplements. The company markets its offerings predominantly under various brand names through an extensive network of independent distributors. Established in 1950, its corporate headquarters are situated in Mumbai, India.
- Sector
- General
- Industry
- Drug Manufacturers - General
- CEO
- Meenakshi Nevatia
- Employees
- 1,244
- Website
- www.pfizerltd.co.in
- Address
- The Capital, Mumbai, MA, 400 051, IN
PFIZER LIMITED (PFIZER) Earnings & Revenues
PFIZER Earnings Call
Earnings Call SentimentPositive
Pfizer's earnings call reflected a strong financial performance with solid revenue and EPS growth, driven by effective cost management and advancements in the R&D pipeline. However, challenges such as impacts from the IRA Medicare Part D redesign and ongoing geopolitical uncertainties pose potential risks.
View all IN:PFIZER earnings summariesTechnical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 1 | 6 | 15 |
| Technical Analysis | 1 | 6 | 3 |
| Moving Averages | 0 | 0 | 12 |
Similar Stocks
| Company | Price & Change | Follow |
|---|---|---|
| IN:ABBOTINDIAAbbott India Limited | ||
| IN:CIPLACipla Ltd | ||
| IN:GLANDGland Pharma Ltd. | ||
| IN:GLAXOGlaxoSmithKline Pharmaceuticals Limited | ||
| IN:SANOFISanofi India Limited |





